HIGHLIGHTS
- What: For SMKIs approved by the FDA between 2018 and 1 March 2024, the authors provide a summary based on timelines and targets in Figure 2. In this sum‑ mary, the authors focus on Aurora kinases (AURKs), which are serine/threonine kinases involved in centrosome maturation, spindle assembly, chromosome alignment, and cytokinesis dur‑ ing mitosis (AURK‑A, B) and meiosis (AURK‑C) .
- Who: Jiahao Li and colleagues from the Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science have published the Article: Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.